|
Allergan did not submit this mdr within 30 days of becoming aware.Recent stimulated reporting related to 2011068-7/2/19-001-r has increased complaint and mdr volume.Allergan is implementing a plan to address the increased volumes.A review of the device history record has been initiated.If any new, changed or corrected information is noted, a supplemental medwatch will be submitted.Device evaluation: visual analysis of the returned device identified deformation, wear abrasion, voids, partial delamination of orientation dot, creases, and cloudiness in the gel observed after autoclave disinfection process.Weight measurement of the device identified device weight was within specification.A microscopic analysis was performed which identified total/partial delamination of orientation dot.Based on the device analysis the final assessment was total/partial delamination of orientation dot due to adhesive failure.The event of "capsular contracture" is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.Reason for reoperation: capsular contracture, baker grade unknown.
|